Cytomx Therapeutics Stock Price History
CTMX Stock | USD 2.43 0.04 1.67% |
Below is the normalized historical share price chart for CytomX Therapeutics extending back to October 08, 2015. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of CytomX Therapeutics stands at 2.43, as last reported on the 23rd of July, with the highest price reaching 2.47 and the lowest price hitting 2.36 during the day.
If you're considering investing in CytomX Stock, it is important to understand the factors that can impact its price. CytomX Therapeutics is abnormally volatile given 3 months investment horizon. CytomX Therapeutics secures Sharpe Ratio (or Efficiency) of 0.16, which signifies that the company had a 0.16 % return per unit of risk over the last 3 months. We have collected data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 2.85% are justified by taking the suggested risk. Use CytomX Therapeutics Downside Deviation of 6.88, mean deviation of 7.39, and Risk Adjusted Performance of 0.1644 to evaluate company specific risk that cannot be diversified away. At this time, CytomX Therapeutics' Stock Based Compensation is fairly stable compared to the past year. Sale Purchase Of Stock is likely to rise to about 133.1 M in 2025, despite the fact that Total Stockholder Equity is likely to grow to (433.2 K). . Price Earnings Ratio is likely to rise to 2.87 in 2025, whereas Price To Sales Ratio is likely to drop 0.60 in 2025. CytomX Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 8th of October 2015 | 200 Day MA 1.2402 | 50 Day MA 2.3017 | Beta 2.12 |
Sharpe Ratio = 0.1598
Best Portfolio | Best Equity | |||
Good Returns | CTMX | |||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
17.85 actual daily | 96 96% of assets are less volatile |
Expected Return
2.85 actual daily | 57 57% of assets have lower returns |
Risk-Adjusted Return
0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average CytomX Therapeutics is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CytomX Therapeutics by adding it to a well-diversified portfolio.
Price Book 15.0003 | Enterprise Value Ebitda 8.0756 | Price Sales 2.5411 | Shares Float 60.9 M | Wall Street Target Price 5.5 |
CytomX Therapeutics Stock Price History Chart
There are several ways to analyze CytomX Stock price data. The simplest method is using a basic CytomX candlestick price chart, which shows CytomX Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | June 12, 2025 | 2.99 |
Lowest Price | April 29, 2025 | 0.65 |
CytomX Therapeutics July 23, 2025 Stock Price Synopsis
Various analyses of CytomX Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell CytomX Stock. It can be used to describe the percentage change in the price of CytomX Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of CytomX Stock.CytomX Therapeutics Price Action Indicator | 0.04 | |
CytomX Therapeutics Price Rate Of Daily Change | 1.02 | |
CytomX Therapeutics Price Daily Balance Of Power | 0.36 | |
CytomX Therapeutics Accumulation Distribution | 72,863 |
CytomX Therapeutics July 23, 2025 Stock Price Analysis
CytomX Stock Price History Data
The price series of CytomX Therapeutics for the period between Thu, Apr 24, 2025 and Wed, Jul 23, 2025 has a statistical range of 2.36 with a coefficient of variation of 36.78. The prices are distributed with arithmetic mean of 1.98. The median price for the last 90 days is 2.32.Open | High | Low | Close | Volume | ||
07/23/2025 | 2.39 | 2.47 | 2.36 | 2.43 | 1,636,097 | |
07/22/2025 | 2.38 | 2.44 | 2.32 | 2.39 | 1,602,045 | |
07/21/2025 | 2.38 | 2.50 | 2.32 | 2.38 | 994,241 | |
07/18/2025 | 2.42 | 2.50 | 2.38 | 2.38 | 676,078 | |
07/17/2025 | 2.42 | 2.50 | 2.38 | 2.38 | 973,935 | |
07/16/2025 | 2.40 | 2.47 | 2.38 | 2.39 | 965,065 | |
07/15/2025 | 2.37 | 2.45 | 2.37 | 2.40 | 644,429 | |
07/14/2025 | 2.39 | 2.43 | 2.36 | 2.39 | 816,509 | |
07/11/2025 | 2.60 | 2.63 | 2.40 | 2.42 | 1,549,801 | |
07/10/2025 | 2.50 | 2.79 | 2.44 | 2.60 | 3,722,992 | |
07/09/2025 | 2.46 | 2.54 | 2.39 | 2.49 | 2,246,708 | |
07/08/2025 | 2.37 | 2.48 | 2.33 | 2.40 | 1,349,035 | |
07/07/2025 | 2.47 | 2.47 | 2.36 | 2.37 | 1,986,766 | |
07/03/2025 | 2.50 | 2.52 | 2.44 | 2.50 | 755,783 | |
07/02/2025 | 2.35 | 2.51 | 2.34 | 2.48 | 780,863 | |
07/01/2025 | 2.28 | 2.38 | 2.15 | 2.36 | 2,573,468 | |
06/30/2025 | 2.25 | 2.39 | 2.22 | 2.27 | 2,264,985 | |
06/27/2025 | 2.32 | 2.44 | 2.23 | 2.25 | 2,535,785 | |
06/26/2025 | 2.20 | 2.40 | 2.18 | 2.31 | 1,974,444 | |
06/25/2025 | 2.17 | 2.28 | 2.10 | 2.21 | 2,001,993 | |
06/24/2025 | 2.12 | 2.22 | 2.10 | 2.14 | 1,386,912 | |
06/23/2025 | 2.32 | 2.32 | 2.10 | 2.16 | 2,403,958 | |
06/20/2025 | 2.15 | 2.38 | 2.15 | 2.32 | 8,057,260 | |
06/18/2025 | 2.39 | 2.39 | 2.08 | 2.11 | 4,132,785 | |
06/17/2025 | 2.48 | 2.53 | 2.33 | 2.38 | 2,038,089 | |
06/16/2025 | 2.83 | 2.87 | 2.46 | 2.46 | 2,837,133 | |
06/13/2025 | 2.95 | 3.10 | 2.71 | 2.75 | 1,972,847 | |
06/12/2025 | 2.80 | 3.00 | 2.75 | 2.99 | 1,796,133 | |
06/11/2025 | 2.73 | 2.89 | 2.66 | 2.82 | 2,110,624 | |
06/10/2025 | 2.63 | 2.83 | 2.57 | 2.70 | 2,552,986 | |
06/09/2025 | 2.66 | 2.88 | 2.63 | 2.64 | 4,284,712 | |
06/06/2025 | 2.46 | 2.71 | 2.43 | 2.64 | 3,414,356 | |
06/05/2025 | 2.47 | 2.58 | 2.35 | 2.40 | 2,206,826 | |
06/04/2025 | 2.65 | 2.75 | 2.51 | 2.51 | 2,116,050 | |
06/03/2025 | 2.50 | 2.67 | 2.46 | 2.65 | 1,515,070 | |
06/02/2025 | 2.63 | 2.82 | 2.45 | 2.51 | 3,123,394 | |
05/30/2025 | 2.53 | 2.71 | 2.45 | 2.65 | 3,903,128 | |
05/29/2025 | 2.40 | 2.59 | 2.38 | 2.52 | 3,551,057 | |
05/28/2025 | 2.13 | 2.64 | 2.12 | 2.40 | 5,241,440 | |
05/27/2025 | 2.27 | 2.30 | 2.10 | 2.13 | 3,738,101 | |
05/23/2025 | 2.06 | 2.29 | 2.03 | 2.23 | 3,095,268 | |
05/22/2025 | 2.02 | 2.23 | 2.01 | 2.13 | 3,723,266 | |
05/21/2025 | 2.00 | 2.11 | 1.98 | 2.04 | 2,791,890 | |
05/20/2025 | 2.14 | 2.15 | 1.97 | 2.06 | 7,588,940 | |
05/19/2025 | 2.02 | 2.25 | 2.00 | 2.13 | 4,582,982 | |
05/16/2025 | 2.06 | 2.16 | 1.95 | 2.03 | 5,864,587 | |
05/15/2025 | 2.50 | 2.50 | 1.87 | 2.00 | 9,166,017 | |
05/14/2025 | 2.37 | 2.38 | 2.01 | 2.38 | 7,912,981 | |
05/13/2025 | 2.17 | 2.55 | 1.86 | 2.50 | 24,228,466 | |
05/12/2025 | 1.90 | 2.18 | 1.65 | 2.13 | 113,675,414 | |
05/09/2025 | 1.29 | 1.30 | 0.91 | 0.93 | 15,444,240 | |
05/08/2025 | 0.99 | 1.19 | 0.98 | 1.09 | 5,763,587 | |
05/07/2025 | 0.96 | 1.00 | 0.92 | 0.96 | 2,075,978 | |
05/06/2025 | 0.97 | 1.04 | 0.90 | 0.97 | 2,549,773 | |
05/05/2025 | 0.88 | 1.00 | 0.84 | 0.96 | 4,507,591 | |
05/02/2025 | 0.77 | 0.83 | 0.76 | 0.80 | 1,418,390 | |
05/01/2025 | 0.74 | 0.77 | 0.72 | 0.76 | 736,597 | |
04/30/2025 | 0.65 | 0.74 | 0.63 | 0.74 | 1,656,247 | |
04/29/2025 | 0.72 | 0.72 | 0.64 | 0.65 | 1,992,397 | |
04/28/2025 | 0.74 | 0.77 | 0.70 | 0.71 | 4,075,681 | |
04/25/2025 | 0.77 | 0.77 | 0.70 | 0.71 | 715,718 |
About CytomX Therapeutics Stock history
CytomX Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for CytomX is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in CytomX Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing CytomX Therapeutics stock prices may prove useful in developing a viable investing in CytomX Therapeutics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 84.7 M | 51.9 M | |
Net Loss | -104.3 M | -109.5 M |
CytomX Therapeutics Quarterly Net Working Capital |
|
CytomX Therapeutics Stock Technical Analysis
CytomX Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Bonds Directory Now
Bonds DirectoryFind actively traded corporate debentures issued by US companies |
All Next | Launch Module |
CytomX Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for CytomX Therapeutics' price direction in advance. Along with the technical and fundamental analysis of CytomX Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of CytomX to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.1644 | |||
Jensen Alpha | 1.97 | |||
Total Risk Alpha | (0.27) | |||
Sortino Ratio | 0.404 | |||
Treynor Ratio | 0.5055 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for CytomX Stock Analysis
When running CytomX Therapeutics' price analysis, check to measure CytomX Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CytomX Therapeutics is operating at the current time. Most of CytomX Therapeutics' value examination focuses on studying past and present price action to predict the probability of CytomX Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CytomX Therapeutics' price. Additionally, you may evaluate how the addition of CytomX Therapeutics to your portfolios can decrease your overall portfolio volatility.